Komori
Nakamoto Packs (7811) · RiskRestated

Lower Prices and Market Share Due to Competitors' Low-Price Strategies and Imitation

First written in FY2017. 4 of 8 entries say "Restated". Latest entry: FY2020.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018RestatedFY2019-Q2 – FY2019-Q3MaterialisedFY2020-Q2 – FY2020-Q32017: 120172018: 320182019: 220192020: 22020
Same theme, other companies
Declining selling prices and lower profits due to intensifying competition with other companiesA theme 226 companies write about · 227 as a headwind · 0 as a tailwind

Nakamoto Packs moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2026: 41 of 85 companies on the "Worse" side.

106 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 227 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2020RestatedAnnual report

    「If competitors' low-price strategies or imitation become evident, lower selling prices and market share could affect the operating results of the Group.」

    The risk of lower prices and market share due to competitors' low-price strategies and imitation continues.
  2. FY2020-Q3MaterialisedAnnual report

    「In addition to demand being concentrated on generic products, the impact of lower selling prices due to drug price revisions and intensifying competition continued. As a result, net sales were ¥1,030 million, up 4.8% year on year, while gross profit was ¥203 million, down 8.7%.」

    Intensifying competition, together with drug price revisions, has affected actual results through lower selling prices and an 8.7% year-on-year decline in gross profit.
  3. FY2020-Q2MaterialisedAnnual report

    「Although orders, particularly for generic products, remained solid, selling prices declined due to the drug price revision and intensified competition. As a result, sales increased 2.4% year on year to ¥651 million, while gross profit fell 12.1% to ¥132 million.」

    The disclosure states that intensified competition actually led to a decline in selling prices and a 12.1% year-on-year decline in gross profit.
  4. FY2019-Q3RestatedAnnual report

    「Although factors including intensified competition with competitors continue to put pressure on profits, gross profit was ¥2,080 million, up 11.7% year on year, due to differentiation through proposals to reduce material usage and offer environmentally conscious printing, as well as price negotiations and proposals to change film structures that were adopted.」

    Although intensified competition with competitors continues, environmentally conscious proposals, price negotiations and proposals to change film structures, including their adoption, are described as responses.
  5. FY2019-Q2RestatedAnnual report

    「Although factors including intensified competition with competitors put pressure on profits, gross profit was ¥1,346 million, up 12.7% year on year, due to price negotiations and proposals to change materials that were adopted.」

    While intensified competition with competitors continues to put pressure on profits, price negotiations and proposals to change materials, including their adoption, are described as responses.
  6. FY2019-Q1MaterialisedAnnual report

    「There was also an impact from higher raw-material prices, intensifying competition with competitors and packaging-material renewals,」

    The disclosure states that intensified competition with competitors actually occurred and affected the order environment for food-related products.
  7. FY2018RestatedAnnual report

    「If competitors’ low-price strategies or imitation become significant, the Group’s business performance could be affected by lower selling prices and market share.」

    The risk of declines in selling prices and market share due to competitors' low-price strategies and imitation continues.
  8. FY2017First statedAnnual report

    「If competitors’ low-price strategies or imitation become significant, the Group’s business performance could be affected by lower selling prices and market share.」

    The disclosure identifies the risk that intensified competition in areas where the Company cannot demonstrate uniqueness or competitive advantages may reduce selling prices and market share.
Moved together

"Stagnant Domestic Economy and Weak Consumer Spending" moved the same way as this thread, in the same document, in 3 of its 8 moves.

3322★1234
  1. ★This thread
  2. 1Stagnant Domestic Economy and Weak Consumer Spending3×
  3. 2Impact of Yen Appreciation on Yen-Translated Amounts and Earnings3×
  4. 3Uncertainty in the Global Economy from the Chinese Slowdown and the United Kingdom's Exit from the EU2×
  5. 4Uncertainty over Mobile-Related Orders Due to Slow Growth in the Smartphone Market2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nakamoto Packs yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Lower Prices and Market Share Due to Competitors' Low-Price Strategies and Imitation | NAKAMOTO PACKS CO.,LTD. (7811) | Komori